Breaking News, Collaborations & Alliances

Sanofi-Aventis, Avila Enter Global Oncology Alliance

Avila Therapeutics, Inc. has signed a worldwide strategic alliance with Sanofi-Aventis to discover targeted covalent drugs for the treatment of cancers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avila Therapeutics, Inc. has signed a worldwide strategic alliance with Sanofi-Aventis to discover targeted covalent drugs for the treatment of cancers. SA will have a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration. The two companies will work together to design targeted covalent drugs directed towards six signaling proteins that are critical in tumor cells. For the selected targets, SA will have access to Avila’s Avilomics pl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters